151 related articles for article (PubMed ID: 10533828)
1. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function.
Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ
Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal antibodies to Rh0(D).
Foung SK; Blunt JA; Wu PS; Ahearn P; Winn LC; Engleman EG; Grumet FC
Vox Sang; 1987; 53(1):44-7. PubMed ID: 3116771
[TBL] [Abstract][Full Text] [Related]
3. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
Kumpel BM
Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.
Hadley AG; Kumpel BM
Immunology; 1989 Aug; 67(4):550-2. PubMed ID: 2504663
[TBL] [Abstract][Full Text] [Related]
5. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
6. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
[TBL] [Abstract][Full Text] [Related]
7. An in-vitro assessment of the functional activity of monoclonal anti-D.
Hadley AG; Kumpel BM; Leader K; Merry AH; Brojer E; Zupanska B
Clin Lab Haematol; 1989; 11(1):47-54. PubMed ID: 2495881
[TBL] [Abstract][Full Text] [Related]
8. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
Kumpel BM
Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805
[TBL] [Abstract][Full Text] [Related]
9. Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies.
Paterson T; Innes J; McMillan L; Downing I; Carter MC
Immunotechnology; 1998 Jun; 4(1):37-47. PubMed ID: 9661813
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
[TBL] [Abstract][Full Text] [Related]
11. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
[TBL] [Abstract][Full Text] [Related]
12. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
[TBL] [Abstract][Full Text] [Related]
13. Functional activity of human Rh monoclonal antibodies (MABS).
Kumpel BM
J Immunogenet; 1990; 17(4-5):321-30. PubMed ID: 2128776
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte antibody-dependent cytotoxicity test for evaluation of clinical role of monoclonal anti-D-antibodies for prevention of rhesus sensitization.
Olovnikova NI; Belkina EV; Nikolaeva TL; Miterev GY; Chertkov IL
Bull Exp Biol Med; 2006 Jan; 141(1):57-61. PubMed ID: 16929965
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
[TBL] [Abstract][Full Text] [Related]
16. Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti-D.
Nielsen LK; Green TH; Norderhaug L; Sandlie I; Dziegiel MH
Transfusion; 2007 Feb; 47(2):306-15. PubMed ID: 17302778
[TBL] [Abstract][Full Text] [Related]
17. Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.
Díaz-Solano D; Fuenmayor J; Montaño RF
Blood Transfus; 2018 Feb; 16(2):200-208. PubMed ID: 28686149
[TBL] [Abstract][Full Text] [Related]
18. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
Kumpel BM; Hadley AG
Mol Immunol; 1990 Mar; 27(3):247-56. PubMed ID: 2111455
[TBL] [Abstract][Full Text] [Related]
19. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
[TBL] [Abstract][Full Text] [Related]
20. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
